Medication Assisted Therapies in Addiction Recovery: A Counselor's Comprehensive Guide
Summary
This podcast episode provides an in-depth look at Medication Assisted Therapies (MAT) for addiction, primarily aimed at mental health counselors. The core purpose of MAT in early recovery is multifaceted: to significantly reduce cravings, alleviate anxiety and depressive symptoms, and foster a greater sense of hope, self-efficacy, and control in clients. The speaker emphasizes that MAT serves as a crucial stabilizing tool, likened to "walking sticks" for climbing a mountain, enabling individuals to gain the clarity and energy needed to actively participate in their recovery process. It is explicitly stated that MAT is not a standalone solution but a vital component that complements counseling, with the placebo effect also acknowledged as a contributor to positive outcomes.
A significant focus is placed on the prevalence of co-occurring mental health issues, which are presented as the norm rather than the exception in individuals struggling with addiction. The episode explains how addictive behaviors disrupt neurotransmitter balance, leading to profound discomfort, anxiety, and depression that often precipitate relapse. MAT is highlighted for its ability to help stabilize these neurochemical imbalances, thereby reducing the intense urge to escape through substance use and supporting individuals in maintaining abstinence during the critical early recovery phase. This period allows the body and brain to rest, recover, and begin to rebalance, setting a foundation for long-term sobriety.
The discussion differentiates between MAT availability for various substances. While pharmacotherapies are established for smoking, alcohol, and opioids, the episode notes a lack of FDA-approved MATs for stimulants, hallucinogens, inhalants, and marijuana. For these substances, the approach shifts to understanding the underlying psychological and neurochemical functions of their use—such as seeking energy, empathy, or anxiety reduction—to guide broader treatment strategies, often involving existing psychiatric medications like antidepressants to address symptomatic relief and underlying mood disorders.
Finally, the episode addresses practical considerations and systemic challenges associated with MAT. These include the financial cost of medications (with solutions like patient assistance programs mentioned), issues of availability (e.g., methadone clinics), potential side effects, and significant barriers such as workplace drug testing and restrictive incarceration policies that often discontinue essential medications. A critical point is the pervasive stigma surrounding MAT, particularly from some 12-step groups and even some counselors, which is contrasted with the scientific evidence supporting its efficacy for short-to-moderate term use (typically six months to five or six years) as an integral part of a comprehensive, counseling-inclusive recovery plan. Client motivation and willingness to engage in counseling are underscored as essential for MAT success.
Key Quotes
"medication assisted therapies can help reduce their desire their compulsion their obsession to go back out and and use in order to feel that feeling again"
"I don't care where the effects coming from if it's a positive effect I'm pretty darn happy"
"medication assisted therapy can help patients have something to focus on to say okay I've got this tool now"
"depression goes with hopelessness and helplessness so if we can encourage them to focus on the fact well this medication assisted therapy may help you not have the cravings it may make it easier to get through this early recovery period"
"most people in early recovery have co-occurring issues"
"just giving them a pill is not going to fix everything it helps them stabilize so they have the energy and the clear-headedness hopefully to participate in their recovery process"
"medication-assisted therapy plays a critical pivotal role in early recovery helping people start reestablishing a new drug-free life it's not a substitute for counselling"
"the co-occurring model of addiction now I want you to just kind of remember this as we're talking says that co-occurring disorders are the expectation"
"addictive behaviors were learned as a way to stop de-stress and learned behaviors cannot be unlearned"
"the science is really supportive of MAT in short to moderate term and like I said we're talking six months to maybe five or six years"
Concepts
Themes
- Integrated Addiction Treatment
- Neurobiological Underpinnings of Addiction
- The Complementary Role of Medication and Counseling
- Addressing Stigma and Misconceptions
- Patient Empowerment and Hope
- Challenges in Treatment Access and Compliance
- The Expectation of Co-occurring Disorders
Related to:
Health Insights
Therapeutic Techniques Mentioned
- Motivational Interviewing (implied)
- Distress Tolerance (implied)
- Behavioral and Lifestyle Changes
Pharmacological Agents Discussed
- Cipro mean
- Zoloft
- Prozac
- Paxil
- Ketamine
- Dextromethorphan
- Benadryl
- Dramamine
- Methadone
- Buprenorphine
- Suboxone
- Vivitrol
Addictive Substances Covered
- Smoking
- Alcohol
- Opioids
- Stimulants (amphetamines, cocaine, Adderall)
- Hallucinogens (LSD, PCP, psychedelics, dissociatives, deliriants)
- Inhalants
- Marijuana (including Spice/synthetic THC)
Clinical Settings Discussed
- Detox unit
- Crisis stabilization unit
- Methadone clinics
- Residential treatment facilities
Contraindications And Risks
- Benzodiazepines with buprenorphine/methadone
- Nicotine replacement therapy with smoking (some specific drugs)
- Deliriants (narrow therapeutic index/lethal dose)
- Synthetic THC (Spice) causing cardiac issues and paralysis
Neurotransmitters Impacted
- Norepinephrine
- Serotonin
- Dopamine
- Glutamate
- Acetylcholine
Similar Episodes
Medication-Assisted Therapies: An Integrated Approach to Addiction Recovery
Understanding Depression: Symptoms, Neurobiology, and its Interplay with Addiction and Recovery Strategies
Exploring the Course, Continuum, and Interventions for Co-Occurring Mental Health and Addictive Disorders